Janina Gasthaus

Janina Gasthaus

Auto-generated profile, based on publicly available information

Janina Gasthaus

Biotech Research and Innovation Centre (BRIC), Faculty of Health, University of Copenhagen, Copenhagen N, Denmark

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2019 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
NVNavneet A. Vasistha
Navneet A. Vasistha
MPMaria Pardo-Navarro
Maria Pardo-Navarro
JGJanina Gasthaus
Janina Gasthaus
DWDilys Weijers
Dilys Weijers
MBMichaela Kerstin Back
Michaela Kerstin Back
KKKonstantin Khodosevich
Konstantin Khodosevich
Severe infections during pregnancy are one of the major risk factors for cognitive impairment in the offspring. It has been suggested that maternal inflammation leads to dysfunction of cortical GABAergic interneurons that in turn underlies cognitive impairment of the affected offspring. However, the evidence comes largely from studies of adult or mature brains and how the impairment of inhibitory circuits arises upon maternal inflammation is unknown. Here we show that maternal inflammation affects multiple steps of cortical GABAergic interneuron development, i.e., proliferation of precursor cells, migration and positioning of neuroblasts, as well as neuronal maturation. Importantly, the development of distinct subtypes of cortical GABAergic interneurons was discretely impaired as a result of maternal inflammation. This translated into a reduction in cell numbers, redistribution across cortical regions and layers, and changes in morphology and cellular properties. Furthermore, selective vulnerability of GABAergic interneuron subtypes was associated with the stage of brain development. Thus, we propose that maternally derived insults have developmental stage-dependent effects, which contribute to the complex etiology of cognitive impairment in the affected offspring.

21 September 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
VKVera Kloten
Vera Kloten
NRNadine Rüchel
Nadine Rüchel
NBNadina Ortiz Brüchle
Nadina Ortiz Brüchle
JGJanina Gasthaus
Janina Gasthaus
NFNils Freudenmacher
Nils Freudenmacher
Edgar DahlEdgar Dahl
Edgar Dahl
Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR Liquid biopsy in colon cancer: comparison of different circulating dna extraction systems following absolute quantification of KRAS mutations using intplex allele-specific PCR

11 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VKVera Kloten
Vera Kloten
MSMartin Schlensog
Martin Schlensog
JEJulian Eschenbruch
Julian Eschenbruch
JGJanina Gasthaus
Janina Gasthaus
JTJanina Tiedemann
Janina Tiedemann
Edgar DahlEdgar Dahl
Edgar Dahl
NDRG2, a member of the N-myc downstream-regulated gene family, is thought to be a putative tumor suppressor gene with promising clinical impact in breast cancer. Since breast cancer comprises heterogeneous intrinsic subtypes with distinct clinical outcomes we investigated the pivotal role of NDRG2 in basal-type breast cancers. Based on subtype classified tumor (n = 45) and adjacent normal tissues (n = 17) we examined NDRG2 mRNA expression and CpG-hypermethylation, whose significance was further validated by independent data sets from The Cancer Genome Atlas (TCGA). In addition, NDRG2 protein expression was evaluated immunohistochemically using a tissue micro array (TMA, n = 211). In vitro, we investigated phenotypic effects caused by NDRG2 silencing in the basal A-like HCC1806 as well as NDRG2 over-expression in basal A-like BT20 compared to luminal-type MCF7 breast cancer cells. Our tissue collections demonstrated an overall low NDRG2 mRNA expression in breast cancer subtypes compared to normal breast tissue in line with an increased CpG-hypermethylation in breast cancer tissue. Independent TCGA data sets verified a significant (P<0.001) expression loss of NDRG2 in breast tumors. Of interest, basal-like tumors more frequently retained abundant NDRG2 expression concordant with a lower CpG-hypermethylation. Unexpectedly, basal-like breast cancer revealed an association of NDRG2 expression with unfavorable patients’ outcome. In line with this observation, in vitro experiments demonstrated reduced proliferation and migration rates (~20%) in HCC1806 cells following NDRG2 silencing. In contrast, NDRG2 over-expressing luminal-type MCF7 cells demonstrated a 26% decreased proliferation rate. Until now, this is the first study investigating the putative role of NDRG2 in depth in basal-type breast cancer. Our data indicate that the described putative tumor suppressive function of NDRG2 may be confined to luminal- and basal B-type breast cancers.